scholarly journals Participation Rate of Employees of RS X In The Covid-19 Vaccination Program to Break The Chain The Spread of Covid-19

2021 ◽  
Vol 1 (1) ◽  
pp. 205-210
Author(s):  
Kristianto Kristianto

The COVID-19 vaccination aims to reduce the transmission of COVID-19, reduce morbidity and mortality due to COVID-19, achieve herd immunity, and protect the community from COVID-19 to remain socially and economically productive. The role of social media in the era of digital technology can bring positive things as well as negative things, in a positive context there are invitations in the form of motivation to participate in vaccination programs. Meanwhile, in a negative context, the COVID-19 vaccination has become a cornering or scary hoax. However, this news cannot be verified. However, this news greatly influences a person's decision to participate or not in the vaccination program in addition to doubts about the safety of vaccines, doubts about the effectiveness of vaccines, distrust of vaccines, fears of side effects such as fever and pain, and religious reasons. This study will explain the level of participation of workers who work in Hospital X in receiving a prioritized vaccination program for health workers. The research method used is descriptive, where data is collected in the period from January 29, 2021, to May 10, 2021. The vaccination program which is an alternative to breaking the chain of the spread of COVID-19 is welcomed by its implementation in Hospital X with the participation rate of the results. reached 92%. The remaining 8% were not vaccinated because they did not receive a recommendation from a doctor or refused the vaccine because they were worried about the side effects.

Vaccines ◽  
2021 ◽  
Vol 9 (1) ◽  
pp. 44
Author(s):  
Wojciech Feleszko ◽  
Piotr Lewulis ◽  
Adam Czarnecki ◽  
Paweł Waszkiewicz

Background: If globally implemented, a safe coronavirus disease 2019 (COVID-19) vaccination program will have broad clinical and socioeconomic benefits. However, individuals who anticipate that the coronavirus vaccine will bring life back to normality may be disappointed, due to the emerging antivaccination attitude within the general population. Methods: We surveyed a sample of adult Polish citizens (n = 1066), and compared it with the data on international COVID-19 vaccine reluctance. Results: In 20 national surveys, the vaccine averseness for the anticipated COVID-19 vaccine varied from meager (2–6% China) to very high (43%, Czech Republic, and 44%, Turkey) and in most countries was much higher than regular vaccination reluctance, which varies between 3% (Egypt) and 55% (Russia). Conclusions: These results suggest that a 67% herd immunity may be possible only if mandatory preventive vaccination programs start early and are combined with coordinated education efforts supported by legislative power and social campaigns.


2021 ◽  
pp. 2046147X2110140
Author(s):  
Roumen Dimitrov

In this paper I analyse a series of Australian MMR (measles-mumpsrubella) vaccination campaigns and policies from the last decade. Using the Bruno Latour’s Actor Network Theory (ATN), I locate human and non-human mediators – including the virus and vaccine – in the complex pro-vaccination alliance led by government campaigners. I identify the vaccine hesitant parents – a large group that ‘sits on the fence’ between the ‘vaccine confident’ and ‘vaccine refusing’ parents – as the main target of pro-vaccination campaigns. PR literature on pro-vaccination campaigns has applied ATN to the independence of the media as network agents. This paper contributes with the problematisation of several more actors such as the health workers, medical experts and the vaccine hesitant parents themselves. Even when they are keen members of a pro-vaccination network, they cannot be taken for granted. This is where understanding of stigma, silence and voice helps. To align their group interests and discourses, government should know how to communicate strategically – including how to communicate indirectly, avoiding stigma and keeping certain internal affinities and communicative distances intact. In conclusion, I make suggestions about strategic communication in pro-vaccination campaigns. Communication of statistical risks and side effects should be central. It is a winning strategy because it establishes a more credible balance between individual rights and collective obligations in achieving herd immunity. And mandating vaccination cannot replace communication. Research shows that legislating compulsory vaccination may have short-term and relatively small effects. They are almost negligible in the long run. Mandate may trigger compliance, but it also causes anger and mistrust. Mandating vaccine has negative side effects. It punishes with economic and cultural sanctions the socially disadvantaged, who are not active refusers. It also has the opposite effect on vaccine hesitant parents. It does not weaken but rather strengthens their resistance to the vaccine and pushes them to the lager of antivaxxers.


Author(s):  
Oksana Romaniv ◽  
◽  
Bohdan Klyapchuk ◽  

A study of the impact of especially contextual on COVID-19 factors of the epidemic (geopolitical, climatic, socio-economic integration, social, including religious, demographic and others) was conducted. The regional dynamics of the epidemic in the Scandinavian countries was analyzed. The spatio-temporal changes of the epidemic indicators in the conditions of loyalty to risk factors (Sweden) and in the conditions of controlled risks (in other countries of the Scandinavian region) were revealed. The current research of scientists on the formation of herd immunity in the population with and without vaccination programs was generalized. The article evaluated the quality of the vaccination program in Ukraine. The threshold indicator "herd immunity" and the number of months to achieve herd immunity in Ukraine without vaccination were calculated according to a special method.


Author(s):  
N.M. Rai Widiastuti ◽  
N.L.P Suaryani ◽  
Mangku Karmaya

Background and purpose: The Indonesian Demographic Health Survey of 2012 indicated that the prevalence of contraceptive use in Bali Province has decreased compared to 2007. In addition, the proportion of the use an intrauterine device (IUD) also continues to decline. To increase number of IUD acceptors is to promote post-placental intrauterine device (PPIUCD), however the acceptance remains low. This study aims to determine factors associated with acceptance of post-placental intrauterine device in Denpasar.Methods: Study was cross sectional with a total of 100 respondents selected by consecutive sampling. Respondents were mothers who had gave birth in January-February 2016 at Wangaya General Hospital and three health centers (Dauh Puri Sub Health Center, East Denpasar I and South Denpasar IV). Data were collected by interview in hospital and health center. Chi square test was conducted for bivariate analysis and multivariate using logistic regression.Results: Proportion of PPIUCD acceptance was 35%. Multivariate analysis indicated that PPIUCD acceptance was associated with perception of benefits (AOR=10.39; 95% CI: 2.792-38.56), perception of low side effects (AOR=5.288; 95%CI: 1.085-25.761), role of health workers (AOR=7.1; 95%CI: 1.781-28.60) and support of the husband (AOR=12.020; 95% CI=2.888-50.01).Conclusion: Variables associated with PPIUCD acceptance were perception of low side effects, perception of benefits, role of health workers and husband support.


2021 ◽  
Author(s):  
Wen Zheng ◽  
Xuemei Yan ◽  
Zeyao Zhao ◽  
Juan Yang ◽  
Hongjie Yu

Abstract Introduction: China is facing substantial risks of imported COVID-19 cases and a domestic resurgence in the long run, and COVID-19 vaccination is expected to be the long-lasting solution to end the pandemic. We aim to estimate the size of the target population for COVID-19 vaccination at the provincial level and summarize the current progress of vaccination programs, which could support local governments in the timely determination and adjustment of vaccination policies and promotional measures.Methods: By extracting provincial-stratified data from publicly available sources, we estimated the size of priority target groups for vaccination programs and further characterized the ongoing COVID-19 vaccination program at the provincial level, including the total doses administered, the coverage rate, and the vaccination capacity needed to achieve the target coverage of 70%.Results: The size of the target population shows large differences among provinces, ranging from 3.5 million to 115.2 million. As of June 10, the speed of vaccine roll-out differs remarkably as well, with the highest coverage occurring in Beijing and Shanghai, where 69.8% and 62.3% of the population is fully vaccinated, respectively. However, in 19 of 31 provinces, less than 40% of the population was administered at least one dose, in 9 of which the proportion was even less than 30%. Compared to the routine vaccination capacity before the COVID-19 pandemic, the COVID-19 vaccination capacity has greatly improved. Nevertheless, the current vaccination capacity is far lower than the target of 70% coverage by the end of 2021 or by mid-2022 in approximately 5%-20% of provinces, particularly the Guizhou, Yunnan, Xinjiang, Fujian and Hebei provinces.Conclusions: Large disparities exist in the target population size and vaccination progress across provinces in China. Vaccine coverage is far from meeting the herd immunity threshold, and the vaccination service capacity needs to be further improved.


2011 ◽  
Vol 204 (3) ◽  
pp. 372-376 ◽  
Author(s):  
Marc Brisson ◽  
Nicolas van de Velde ◽  
Eduardo L. Franco ◽  
Mélanie Drolet ◽  
Marie-Claude Boily

2021 ◽  
Author(s):  
Hengcong Liu ◽  
Juanjuan Zhang ◽  
Jun Cai ◽  
Xiaowei Deng ◽  
Cheng Peng ◽  
...  

To allow a return to a pre-COVID-19 lifestyle, virtually every country has initiated a vaccination program to mitigate severe disease burden and control transmission; over 3.6 billion vaccine doses have been administered as of July 2021. However, it remains to be seen whether herd immunity will be within reach of these programs, especially as more transmissible SARS-CoV-2 variants continue to emerge. To address this question, we developed a data-driven model of SARS-CoV-2 transmission for Shanghai, China, a population with low prior immunity from natural infection. We found that extending the vaccination program to individuals aged 3-17 years plays a key role to reach herd immunity for the original SARS-CoV-2 lineages. With a vaccine efficacy 74% against infection, vaccine-induced herd immunity would require coverages of 93% or higher. Herd immunity for new variants, such as Alpha or Delta, can only be achieved with more efficacious vaccines and coverages above 80-90%. A continuation of the current pace of vaccination in China would reach 72% coverage by September 2021; although this program would fail to reach herd immunity it would reduce deaths by 95-100% in case of an outbreak. Efforts should be taken to increase population's confidence and willingness to be vaccinated and to guarantee highly efficacious vaccines against more transmissible variants of concern.


2021 ◽  
Vol 3 (3) ◽  
pp. 59-64
Author(s):  
Peter C. Oriji ◽  
Dennis O. Allagoa ◽  
Lukman Obagah ◽  
Obielumani I. Oguche ◽  
Onyekachi S. Ohaeri ◽  
...  

Background: Side effect following vaccination usually ranges from mild to moderate and occasionally severe in a small proportion of people. Covid-19 vaccine is no exception as side effects have been reported which are mostly mild to moderate and transient. The chances of any of these side effect following vaccination differ according to the specific COVID-19 vaccine. Objective: To determine the side effect profile of the Health workers that received the COVID-19 vaccination in the Federal Medical Centre, Yenagoa, Bayelsa State, Nigeria. Materials and Method: This study was a descriptive cross-sectional study. It was carried out between 15th and 30th April 2021 among 151 health workers that received COVID-19 vaccination in the Federal Medical Centre, Yenagoa, Bayelsa State, Nigeria. The data were collected with a predesigned questionnaire and were analysed using IBM SPSS 23.0 version. Results: About 52.3% were female health workers, 49.0% were aged between 36–45 years. Side effects were reported in 9 of every 10 health workers who received the vaccine. Most side effects (53.0%) started on the day of vaccination. The most common side effect was pain at the injection site, and it was reported by 104 recipients of the vaccine (68.9%). Fever, headache, tiredness and chills were reported in 57.0%, 49.0%, 47.7% and 43.7%, respectively. Conclusion: As with medications and other vaccines, COVID-19 vaccines have side effects. Protective immunity against COVID-19 is developed following vaccination. In the face of a still rapidly evolving situation, what seems obvious is that vaccination currently remains the best route to achieving herd immunity.


2021 ◽  
Vol 11 (4) ◽  
pp. 434-437
Author(s):  
Aanuoluwapo Adeyimika Afolabi ◽  
Olayinka Stephen Ilesanmi

The acceptance of the coronavirus disease 2019 (COVID-19) vaccine has been described as a gateway to attaining herd immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The critical role of community participation (CP) has been successfully demonstrated in previous vaccination programs globally. This perspective therefore aimed to describe how CP could be used to promote COVID-19 vaccination acceptance. To promote COVID-19 vaccine acceptance, it is required that a mapping of community assets, resources, civil-based organizations, and stakeholders is done to gain insight into the community culture and value in relation to COVID-19 vaccine. This will help to address the misconceptions while prompting COVID-19 vaccination sensitization activities that are relevant to each community. It is required that policy makers understand that the adoption of a comprehensive grassroots approach lends a voice to the community and helps to utilize community-initiated and community-driven ideas on promoting COVID-19 vaccine acceptance.


2021 ◽  
Author(s):  
Mohamed Hassan Elnaem ◽  
Nor Hidayah Mohd Taufik ◽  
Norny Syafinaz Ab Rahman ◽  
Nor Ilyani Mohd Nazar ◽  
Che Suraya Zin ◽  
...  

Abstract Background: Vaccination programs are crucial in global efforts to control the COVID-19 pandemic. Little has been reported regarding the attitudes and experiences of participants in the ongoing Malaysian vaccination program. Therefore, this study aimed to investigate the attitudes, perceptions, and experiences of side effects with the COVID-19 vaccines in Malaysia. Methods: This study was a cross-sectional survey conducted among vaccine-eligible and vaccinated individuals in Malaysia between May and July 2021. A self-administered 27-item questionnaire was developed and validated before distributing it through an online medium. Descriptive and inferential statistics were performed using SPSS version 22.Results: A total of 428 respondents completed the survey. More than half of the respondents (71.1%) were 18 to 45 years old, and 66.4% were females. A vast majority (98.6%) of the respondents had registered for the National COVID-19 Vaccination Program. A total of 20 participants (4.7%) expressed their concerns about either registering or receiving the COVID-19 vaccination, and the most reported concern was the uncertainty of vaccine safety. Among the study population, 332 participants (77.5%) received their vaccinations. About 50% received the Pfizer-BioNTech (Cominarty®) vaccine. A majority (76.8%) of the respondents experienced side effects following vaccination. Approximately 40% of the reported side effects occurred more with the second dose, particularly in those who received the Pfizer-BioNTech vaccine (p < .0005). Pain at the injection site (61.1%) and tiredness (48.8%) were the most commonly reported side effects. Those who received Sinovac (CoronaVac®) vaccine were more likely to report fewer side effects than Pfizer-BioNTech (p = .012) and Oxford-AstraZeneca (ChAdOx1-S) groups (p = .001). The logistic regression showed that all age groups, except those aged ≥ 60 years, were more likely to exhibit vaccine-related side effects. Male participants (OR: 0.51, CI:0.27-0.93) and those who received the Sinovac (CoronaVac®) vaccine (OR: 0.08, CI:0.03-0.22) were at lower risk of experiencing vaccine-related side effects.Conclusions: the overall attitudes toward the national vaccination program were positive, with a vast majority registered to be vaccinated. Several differences in the experiences of vaccine-related side effects in terms of prevalence and number were attributed to age, gender, and received vaccine type.


Sign in / Sign up

Export Citation Format

Share Document